Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Noxafil (Posaconazole) Oral Suspension,
Company:  Schering Corporation
Application No.:  022003
Approval Date: 09/15/2006


Date created: November 092006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.